Camber Capital Management LP
Q4 2024 13F Holdings
- Locationboston, MA
- Num holdings
39
- Value ($000)
$4,324
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001444043
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $1.47M | 34 % | 2,500,000 | put | |
MDT MEDTRONIC PLC | SHS | G5960L103 | $219.67K | 5 % | 2,750,000 | ||
VTRS VIATRIS INC | COM | 92556V106 | $186.75K | 4 % | 15,000,000 | ||
ZBH ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | $169.54K | 4 % | 1,605,000 | ||
GSK GSK PLC | SPONSORED ADR | 37733W204 | $169.10K | 4 % | 5,000,000 | call | |
HUM HUMANA INC | COM | 444859102 | $164.91K | 4 % | 650,000 | ||
PTCT PTC THERAPEUTICS INC | COM | 69366J200 | $144.45K | 3 % | 3,200,000 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $141.62K | 3 % | 1,150,000 | ||
BAX BAXTER INTL INC | COM | 071813109 | $134.87K | 3 % | 4,625,000 | ||
CVS CVS HEALTH CORP | COM | 126650100 | $134.67K | 3 % | 3,000,000 |
Rows Per Page
1 - 10 of 3910
- 10
- 50
- 100